A cohort study of patients with acute pancreatitis from New Zealand had shown that the use of insulin during or after the treatment of acute pancreatitis, had increased the risk of developing recurrent acute pancreatitis and chronic pancreatitis by 70% over a mean follow-up period of seven years. The gene discussed is INS; the disease is chronic pancreatitis.